Chloride in Heart Failure Syndrome: Its Pathophysiologic Role and Therapeutic Implication

Hajime Kataoka1

  • 1Internal Medicine, Nishida Hospital, Oita, Japan. hkata@cream.plala.or.jp.

Cardiology and Therapy
|August 16, 2021
PubMed

Insights

Chloride, often overlooked in heart failure (HF) research, plays a crucial role in body fluid distribution. New findings suggest a "chloride theory" for HF pathophysiology, proposing novel therapeutic strategies.

Area of Science:

  • Cardiology
  • Nephrology
  • Electrolyte Balance

Background:

  • Traditional heart failure (HF) research primarily focused on sodium and water balance, neglecting the role of chloride.
  • Chloride, an essential electrolyte, has been historically underestimated in cardiovascular pathophysiology and clinical practice.
  • Emerging evidence highlights chloride's significant influence on body fluid distribution and its potential impact on HF.

Purpose of the Study:

  • To review the historical context of HF pathophysiology.
  • To explore the emerging role of chloride in cardiovascular research and HF.
  • To introduce the proposed 'chloride theory' for HF pathophysiology and suggest new therapeutic avenues.

Main Methods:

  • Literature review of HF pathophysiology, focusing on fluid dynamics.
  • Analysis of the known physiological roles of chloride in the human body.
  • Synthesis of recent findings linking chloride to HF, leading to the 'chloride theory' hypothesis.

Main Results:

  • Chloride is identified as a key electrolyte in tubulo-glomerular feedback and body fluid regulation.
  • Recent research indicates a significant, previously underappreciated role for chloride in HF pathophysiology.
  • The 'chloride theory' proposes a new framework for understanding vascular and organ congestion in HF.

Conclusions:

  • The 'chloride theory' offers a novel perspective on HF pathophysiology, emphasizing chloride's central role.
  • Understanding chloride dynamics can lead to a new classification of HF.
  • This theory opens possibilities for innovative therapeutic strategies targeting chloride balance in HF patients.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
545
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
62
Roles of Electrolytes: Chloride and Bicarbonate01:29

Roles of Electrolytes: Chloride and Bicarbonate

Chloride ions contribute to the osmotic pressure gradient distinguishing the intracellular fluid (ICF) from the extracellular fluid (ECF). They counterbalance positively charged ions in the ECF and ensure its electrochemical stability. The renal system's process of chloride absorption and release generally mirrors that of sodium ions.
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting,...
501
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
108
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
593
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K